Patent Application
20200330543
This invention relates to a topical herbal formulation for wounds and a process for the manufacture thereof. More specifically, this invention relates to a topical wound-healing herbal formulation having anti-inflammatory and anti-microbial properties. The formulation is particularly effective in the management of horse wounds but also has applications for humans and other animals. The formulation also has application as a cosmetic product.
It is well known that horses' wounds take a very long time to heal. A bad cut can be career-ending for a horse and even life-threatening if it becomes infected, which happens all too often due to the slow healing process. Horses are prone to excessive inflammation in the early stages of healing which is painful for the horse and is also an impediment to the healing process. In addition to this, horses tend to produce excessive granulation tissue during healing and the end result is often a raised, hairless scar. This is particularly undesirable as a beautiful, even and shiny coat is highly prized in horses.
There are several preparations available to treat wounds in humans and animals. However, many synthetic antimicrobial agents are also irritants, so while they may prevent infection of a wound, they also inhibit healing. Compositions containing these chemicals are usually unsuitable for those individuals prone to allergies and many people for a variety of reasons avoid certain chemicals found in disinfecting lotions. In addition to this, organic farming requires the use of non-synthetic treatments where possible.
PCT Patent Application Publication No. WO2009/071213, in the name of Bayer Consumer Care AG, discloses how Centella asiatica is known and used for healing, sedative, analgesic, antidepressant, antiviral and antimicrobial properties. Extracts containing such compounds have been used in the pharmaceutical and cosmetic industries for treating wounds, scars and venous insufficiency as well as for dermis restoration and anti-inflammatory properties.
PCT Patent Application Publication No. WO00/72860, in the name of Larsen, discloses a wound healing article comprising dried and crushed leaves from Plantago major.
The article entitled “Wound Healing Activity of Acylated Iridoid Glycosides from Scrophularia nodosa”, in the name of Stevenson et al, published in Phytotherapy Research Volume 16, Pages 33-35 (2002) describes how Figwort has been known to be used in the treatment of wounds.
PCT Patent Application Publication No. WO2007/03066, in the name of Herbal Intervention Corporation, discloses a herbal skin care composition for the promotion of wound healing comprising, inter alia, yarrow and plantain extracts.
The article entitled “A review of phytochemistry and medicinal properties of the genus Achillea”, in the name of Saeidnia et al, published in the journal DARU, Volume 19, No. 3 (2011) describes how yarrow is known to treat wounds. The webpage http://www.goinherbs.com/?sn=1614-4 discloses a lotion made with Pau d'Arco for use with a variety of skin diseases and infections for its antibacterial, antifungal and anti-inflammatory benefits. The webpage http://www.alternative-healthzine.com/echinacea-wonder-herb/ describes how Echinacea is known for use in the treatment of wounds.
U.S. Pat. No. 3,809,749, in the name of Amazon Natural Drug Company discloses how the sap from the tree Croton lechleni may be used in the manufacture of a pharmaceutical composition for topical use in the treatment of skin wounds. With the exception perhaps of WO2007/03066, little has been done to consider the potential benefits of combining two or more of these known components in the treatment of wounds.
This invention aims to overcome at least one of the above-mentioned problems and provide a useful choice to the consumer.
According to the invention there is provided a topical healing formulation comprising:
This has been found to be a particularly beneficial combination of ingredients for healing and it has been found that when these components are combined that they provide a synergistic healing effect, not limited to animal topical application, but also with humans. Firstly, when applied to a wound before healing begins the formulation prevents infections. Gotu kola has antibacterial components and there is evidence that it also increases collagen production which aids wound healing. It is vitally important to prevent infection of a wound with antibacterial and antifungal treatments in addition to cleaning and dressing the wound. This is particularly the case with animal wounds which may be difficult to wash and keep clean. In the case of skin disorders, damaged, cracked skin can become infected very easily compared to healthy skin and it is essential to prevent this. The formulation also helps to control inflammation. Much of the damage caused to a horse's coat during healing is due to excessive inflammation and for this reason controlling inflammation is a priority in wound management. In skin disorders, inflammation causes itching and pain and also manifests as redness, which is undesirable for cosmetic reasons. Greater Plantain, Figwort and Pau d'Arco are effective as anti-inflammatory ingredients. Yarrow has a variety of useful healing properties including anti-inflammatory activity and an ability to slow bleeding and has been found to improve the efficacy of the formulation. Yarrow magnifies the other herbs active constituents. The formulation according to the invention is designed to clean the wound before healing begins.
In one embodiment of the invention there is provided a topical healing formulation further comprising a carrier base. The carrier base extracts the active compounds from the plants and ensures that the active compounds are in contact with the wound where they are needed. The carrier base can also form a seal around the wound and help the wound to retain moisture while preventing ingress of bacteria.
In one embodiment of the invention there is provided a topical healing formulation in which the carrier base comprises petrolatum. Petrolatum is very effective at extracting the active components of the plants and will form a protective barrier on the wound which will help prevent infection and prevent drying out of the wound. In addition to this it is generally well-tolerated and non-allergenic, it has a low cost and it does not oxidise. Petrolatum also has a suitable viscosity for application to a wound in a thick layer if necessary and will not rub off easily which is a very useful quality if the preparation is to be used on an animal without a dressing.
In one embodiment of the invention there is provided a topical healing formulation comprising 1% to 12% Gotu Kola, between 1% to 12% Common Plantain, between 1% to 12% Figwort, between 1% to 12% Yarrow and between 1% to 12% Pau d'Arco. The ranges of 1% to 12% have been found to be adequate for most applications without causing side-effects. These percentages refer to the amount of plant used before extraction. After the active components of the plants are extracted from the plants into the carrier base, the remaining plant structures are typically removed by filtration.
In one embodiment of the invention there is provided a topical healing formulation comprising between 6% to 10% Gotu Kola, between 6% to 10% Common Plantain, between 6% to 10% Figwort, between 6% to 10% Yarrow and between 6% to 10% Pau d'Arco. These ranges are particularly suited to wound management which requires a high concentration of active compounds.
In one embodiment of the invention there is provided a topical healing formulation further comprising 1% to 12% Echinacea (Echinacea augustifolia). Echinacea is effective at preventing fungal infections.
In one embodiment of the invention there is provided a topical healing formulation further comprising 6% to 10% Echinacea Echinacea augustifolia.
In one embodiment of the invention there is provided a topical healing formulation further comprising 1 to 12% Sangre de Grado (Dragon's Blood resin). Sangre de Grado/Dragon's Blood resin contains antiseptic compounds and has a substantial thickening effect on the formulation, allowing the formation of an effective seal over the treated skin. This percentage refers to the mass of the Dragon's Blood resin present in the final formulation. It is not further processed or extracted.
In one embodiment of the invention there is provided a topical healing formulation further comprising 6 to 10% Sangre de Grado (Dragon's Blood resin). This is the most effective range for wound management.
In one embodiment of the invention there is provided a topical healing formulation wherein the carrier base comprises one or more of the following: petrolatum, soft white paraffin, emollient, Silcock's base, aqueous cream, jojoba oil, shea butter, coconut oil, Dragon's Blood resin, thickener, stabilizer, essential oil and preservative. These are all capable of extracting the active components from the plants but have different viscosities which may suit different applications. For instance, for cosmetic reasons a less viscous formulation comprising jojoba oil may be preferable for application to the skin of a person's face, but a thicker formulation may be desired for the lips to impart a shine. Furthermore, a less viscous formulation may be adequate for treating skin disorders such as eczema and nappy rash while a more viscous formulation with waxes or thickening agents will be longer lasting and may be applied in a thicker layer, which is advantageous for treating a deep wound. In regions of the world where coconut oil, jojoba oil or shea butter are already used extensively for treating the skin, these may be the preferred carrier bases as there may be a preference among users for ingredients that they are familiar with as this will reduce the risk of an adverse reaction. Essential oils impart a pleasant fragrance on the product and many have further antiseptic properties. The preservative may be provided by way of one or both of Vitamin E and Grapefruit seed extract and the stabiliser may be provided by way of the introduction of both Vitamin E and Grapefruit seed extract.
In one embodiment of the invention there is provided a topical healing formulation comprising one or more of the following oils: olive oil, jojoba oil, almond oil, avocado oil, argan oil, grape seed oil, rapeseed oil, sesame oil, coconut oil, borrage oil and safflower oil. These oils have different viscosities which may be suitable for different applications. Furthermore, a preparation may be made on site from an essential oil of the herbs which comprise the formulation or from the dried herbs which comprise the formulation with an oil of the user's choice. Locally produced oils may be preferable for environmental reasons as they reduce transport costs. Additionally, there may be a preference among users for ingredients that they are familiar with as this will reduce the risk of an adverse reaction.
In one embodiment of the invention there is provided a topical healing formulation comprising one or more of the following thickeners: wheatflour, cornflour, baking powder, arrowroot and slippery elm. A thick formulation may be preferable if a thick layer is to be applied to a wound. In use with a horse or other animal it is also advantageous to use ingredients that occur naturally in the animal's surroundings to reduce the risk of an adverse reaction.
In one embodiment of the invention there is provided a topical healing formulation comprising essential oils from one or more of the following: St. John's Wort (Hypericum perforatum), Goldenseal (Hydrastis canadensis), Lemon balm (Melissa officianalis), chickweed, nettle, Lavender (Lavendula augustifolio), elderflower and Sangre de Grado (Dragon's Blood resin). St. John's Wort is not used in preparations for horses but is advantageous for preparations for human skin.
In one embodiment of the invention there is provided a topical healing formulation further comprising an extract of one or more of the following antifungal agents: clove, tea tree oil and cinnamon bark.
In one embodiment of the invention there is provided a topical healing formulation further comprising Aloe vera (Aloe barbadensis). Aloe vera is a popular treatment for burns.
In one embodiment of the invention there is provided a topical healing formulation in which the formulation is an ointment. This is a particularly preferred embodiment for treating animal wounds or deep wounds because it is difficult to rub off the skin.
In one embodiment of the invention there is provided a topical healing formulation in which the formulation is a cream. This is a particularly preferred embodiment for treating a person's hands and face where the thicker ointment may be unsightly or inconvenient. In one embodiment of the invention there is provided a topical healing formulation in which the formulation is a body butter. This is a preferred embodiment for treating a person's body.
In one embodiment of the invention there is provided a topical healing formulation in which the formulation is an essential oil. It is envisaged that this can then be mixed by the user with a base like Silcock's base or petrolatum.
In one embodiment of the invention there is provided a topical healing formulation in which the formulation is a powder. It is envisaged that this powder can then be mixed by the user with a base like Silcock's base or petrolatum.
In one embodiment of the invention there is provided a topical wound-healing formulation in which the formulation is an oil.
In one embodiment of the invention there is provided a use of the topical healing formulation as a medicament.
In one embodiment of the invention there is provided a use of the topical healing formulation for treating at least one of nappy rash, dry skin, eczema, dermatitis, wounds, infected wounds, suppurating wounds, discharging wounds, burns and skin disorders in humans.
In one embodiment of the invention there is provided a use of the topical healing formulation for treating at least one of hairless scars, de-gloved soft tissue injuries, dermatitis, abrasions, wounds, infected wounds, suppurating wounds, discharging wounds, burns and skin disorders in animals. Specifically, there is provided a use of the topical healing formulation for treating horses.
In one embodiment of the invention there is provided a use of the topical healing formulation in the manufacture of a cosmetic product.
In one embodiment of the invention there is provided a process for producing a topical healing ointment comprising the steps of:
In one embodiment of the invention there is provided a process for producing a topical healing crème comprising the steps of:
In one embodiment of the invention there is provided a process for producing a topical healing essential oil comprising the steps of:
In one embodiment of the invention there is provided a process for producing a topical healing essential oil comprising the steps of:
In one embodiment of the invention there is provided a process for producing a topical healing essential oil comprising the steps of:
In one embodiment of the invention there is provided a process for producing a topical healing powder comprising the steps of:
In one embodiment of the invention there is provided a process for producing a topical healing oil comprising the steps of:
In one embodiment of the invention there is provided a process for producing a topical healing oil in which the oil comprises jojoba oil.
In one embodiment of the invention there is provided a process for producing a topical healing body butter comprising the steps of:
The invention will be more clearly understood from the following description of some embodiments thereof given by way of example only with reference to the accompanying drawings, in which:
The invention will now be more clearly understood from the following description of some embodiments thereof given by way of example only.
According to the invention, there is provided a topical healing formulation comprising a carrier base, preferably, petrolatum, having the following ingredients added thereto: (i) Gotu Kola (Centella asiatica); (ii) Common Plantain (Plantago major); (iii) Figwort (Scrophularia nodosa); (iv) Yarrow (Achillea millefolium); and (v) Pau d'Arco (Tabebuia impetiginosa). The topical healing formulation is suitable for application directly to a wound or other skin disorder. The topical healing formulation may be applied once, twice, thrice daily or more frequently as required. Wounds and skin disorders begin to show improvement after one or more applications.
The herbal formulation may be prepared in a number of forms such as ointment, cream/crème, essential oil, powder, oil and body butter and suitable methods of preparation of these herbal formulations are provided in the following examples. These are given by way of illustration only and should not be construed as limiting the subject matter of the invention.
White soft paraffin was obtained and melted under a low heat until it liquefied. Roughly chopped dried leaves of Figwort, Common Plantain, Pau d'Arco, Gotu Kola and Yarrow were obtained and were added to the liquefied white soft paraffin in the amounts given in tables 1(a) and 1(b) below to form an herbal mix. The herbal mix was maintained at a temperature of between 45° C. and 57.4° C. for between 3 and 96 hours to allow infusion and extraction to form an extracted mixture. The herbal leaves were drained from the extracted mixture and the extracted mixture was placed in a container where it was gently sealed and allowed to cool to form the ointment. The ointment was then packaged.
An alternative ointment comprises 2500 g white soft paraffin infused with 60 g each of Figwort, Common Plantain, Pau d'Arco, Gotu Kola and Yarrow. The chopped herbs were added to the liquefied white soft paraffin to form a herbal mix. The herbal mix was maintained for at least 96 hours to allow infusion and extraction to form an extracted mixture. The herbal leaves were drained from the extracted mixture and the extracted mixture was placed in a container where it was gently sealed and allowed to cool to form the ointment. The ointment was then packaged.
Silcock's base was obtained and an herbal tincture of each of Figwort, Common Plantain, Yarrow, Gotu Kola, Pau d'Arco was obtained and was added gradually to the silcock's base in the amounts given in tables 2(a) and 2(b) below to form an herbal mix.
The herbal mix was mixed slowly so as not to add any air until the herbal mix reached a smooth consistency and formed a crème. The crème was then transferred to containers and sealed.
Roughly chopped leaves of dried Common Plantain, Figwort, Pau d'Arco, Gotu Kola and Yarrow were obtained and were added to water in the amounts given in table 3 below to form an herbal mix. The herbal mix was maintained at room temperature for between 3 hours and 3 weeks to allow infusion and extraction to form an extracted mixture. The herbal leaves were drained from the extracted mixture to leave oil, and the remaining oil was packaged. Alternatively, the essential oil(s) of fresh or dried leaves can be extracted using a steam distillation process or a wax extraction process.
Common Plantain, Yarrow, Figwort, Gotu Kola, Pau d'Arco were obtained in powder form and were added to arrowroot. Alternatively, slippery elm could be used as the base carrier and is considered the preferred base to form an herbal mix. The powders are then thoroughly mixed together and then the powder is packaged.
Roughly chopped dried leaves of Common Plantain, Pau d'Arco Yarrow, Figwort, Gotu Kola and Yarrow were obtained and were placed in a container. The leaves were covered with jojoba oil to form an herbal mix. The herbal mix was maintained at a temperature of between 12° C. and 24° C. for at least 3 weeks to allow infusion and extraction to form an extracted mixture. The herbal leaves are drained from the extracted mixture to leave oil and the remaining oil was packaged.
Beeswax and Shea butter are melted slowly over a low heat, oil and/or essential oils are added and beaten slowly and well. The herbal mix was then turned out into containers and packaged.
In the methods of preparation of the above formulations, it is possible to commercially obtain the herbal leaves in roughly chopped, cut and dried or powder form, tincture and oil. Alternatively, the leaves can be chopped up or ground down using any well known chopping or grinding instrument. It is also possible to obtain herbal tinctures commercially for each of the individual herbs. A tincture is an herb extract prepared by steeping herbs in alcohol (vodka 40% for aerial parts, ethanol for woody parts) for several weeks. The general ratio for herb to alcohol in a tincture is 4:150 however, this can vary.
In the preparation of the ointment, infusion and extraction can take in the region of between 3 and 96 hours, and at a temperature in the region of 57.4 degrees Celsius.
The ointment has been found to be particularly suitable in treating wounds and general skin disorders. The ointment however can also be packaged in the form of a lip balm and has found to be particularly effective in treating and soothing chapped lips. In the preparation of an ointment for lip balm, Lavender, Echinacea and Lemon Balm can be added. It is also possible to prepare a lip-gloss using the same method as the ointment but substituting the white soft paraffin or petroleum jelly with paraffin gel, to provide a glossy look and consistency.
The herbal formulations have been found to be particularly suitable for open wounds and general skin disorders, but have also been found to treat napkin/nappy/diaper rash, bedsores, and eczema, surface wounds, suppurating and discharging wounds. It has been found that by applying the ointment formulations to the human skin of a baby each time the baby's nappy is changed, that this will clear up napkin rash within three nappy changes. In animals, it has been found that by applying the ointment preparation of either once a day, twice a day—morning and evening, or once every two, three or four days, that wounds will clean prior to healing. Following the cleaning phase of the ointment, tissue regeneration and hair re-growth in animals become evident within a 48 hr to 72 hr period.
In humans, it has been found that by applying the crème, oil, or body butter preparation twice a day—morning and evening, that general skin disorders such as eczema, dermatitis, very dry skin and cracked skin clear up. It was further found that the Sangre De Grado eliminates bleeding upon contact. The formulations are particularly suitable for individuals who suffer from allergies, as they do not comprise of any chemicals many of which are allergens.
The ointment formulations prepared have a shelf life of 30 months upon Stability testing. The ointment does not require a challenge test as aqua is not present in the formula and in addition, the formula does not require the use of any types of preservatives or stabilisers—natural, edible, or synthetic.
If a preservative or a stabiliser is to be provided, it is envisaged that two preservatives can be used in combination to stabilize the formula. If possible, previously stabilized and even food grade sources will have been used to avoid the need for further stabilisers and preservatives. However, for example, if non-stabilised/preserved aloe vera gel is used, the formula is likely to develop a mould growth over time. If stabilised/preserved aloe vera is used, such as aloe babandis miller that has previously been stabilized, the formula shouldn't develop mould but it will have to undergo a challenge test if there is aqua present in the formula.
One preservative that may be used with the present formulations is Vitamin E. Vitamin E contains natural antioxidants which extend the life of the products. Gamma tocopherol, a component of Vitamin E, is a great antioxidant for protecting cosmetic formulations. T-50 has a larger amount of gamma tocopherols than other forms of Vitamin E oil. While the alpha tocopherol in the 250, 1000, and 1400 IU/g oils is useful as an in vitro antioxidant, studies show that the gamma tocopherol in the Vitamin E T-50 oil is a better antioxidant for oils/lipids in cosmetic formulations. T-50 has a higher content of gamma tocopherols and can be used at a rate of 0.04% or 400 ppm to adequately protect formulations.
Another preservative that may be used is Grapefruit Seed Extract (GSE). Grapefruit Seed Extract is a citrus seed based anti-microbial used as a preservative in skin care products. GSE is made with the extracts of citrus seeds and pulp. It is blended with vegetable glycerin to make it non-irritating to the skin and mucous membranes when used in formulations. GSE is even safe enough to use as a disinfectant for drinking water when necessary. Grapefruit Seed Extract may be used at professional strength, more specifically it is 60% GSE in 40% vegetable glycerine, rather than the usual 33% found elsewhere. GSE has a shelf life of 7-9 years and it is said to be anti-microbial, anti-septic, anti-bacterial, astringent and does also have some antioxidant activity. The GSE is used at 0.5 to 1% by weight to preserve most formulations, but may be used at 2% by weight of the formulation to create anti-bacterial creams, salves, rinses and soaps. The formulations consisting of Silcox (Silcock's) Base or Aqueous crème have a shelf life of 3 to 12 months, providing the lid is replaced after each use or an airless pump is used as the end delivery system, as exposure to air turns the formulation brown, but does not appear to impinge on the potency. A challenge test would be required and a stability test to determine mould, yeast or bacterial growth, and or degeneration of potency and consistency of formula.
Tabebuia impetiginosa has been found to be the most suitable type of Pau d'Arco as its active constituents appears to be more potent. Scrophularia nodosa is the most potent form of Figwort and thus has been found to be the most suitable. It will be understood that other, less potent forms of Pau d'Arco or Figwort could be used to good effect and may be used depending on availability. Although other herbal agents such as Evening Primrose oil, Safflower oil, and Marigold (Calendula officianilis) can be added to the herbal formulation, Borage (Borago officianilis) has been found to be particularly effective as it has a higher GLA content. The GLA content of a component is defined as the amount of γ-linolenic acid contained therein. GLA is an omega-6 essential fatty acid extracted from the oil seed and has been identified as having several beneficial properties. Echinacea augustifolia is the more potent of Echinacea pallidum and Echinacea purpurea and therefore is seen as preferred when added to the formulation. Borage is not used in preparations for horses.
Ideally, the carrier base is in the amount of between 52% and 95% by weight of the formulation. Preferably, the carrier base is selected from the group comprising one or more of emollient, white soft paraffin/petroleum jelly (petrolatum), Silcox (Silcock's) base, Aqueous crème, paraffin gel, water, oil, Shea butter, coconut butter, Sangre de Grado (Dragons Blood) resin, thickener, stabilizers, essential oils, and preservatives. Further, preferably, the oil is selected from the group comprising one or more of Olive oil, Jojoba oil, Almond oil, Argon oil, Avocado oil, Grape Seed Oil, Sesame Oil, Coconut oil, Borage oil and Safflower oil. Preferably, the thickener is selected from the group comprising one or more of baking powder, flour, arrowroot and slippery elm.
The herbal formulation according to the invention is deemed suitable for use as a therapeutic and/or cosmetic composition for the treatment of tissue regeneration without introduction of an extracellular matrix synthetic, silk or natural. It may be used to regenerate the dermal sheath, repopulate dermal papilla and modulate hair type without introduction of synthetic or induced mesenchymal stem cell epithelial progenitors. Furthermore, the formulation is deemed suitable to treat serious de-gloved soft tissue injuries in horses by regenerating and promoting vascularisation, elastin content and follicle structures without development of granuloma and suitable to treat hairless scars, and general skin disorders from cuts, abrasions to dermatitis in bloodstock. On human skin it should be noted, that tissue regeneration does not occur, nor are follicular impediments altered in a positive way.
The formulation according to the present invention was tested on a number of animals with varying degrees of injury ranging from large wounds to small scars. The results of these tests are outlined in the case studies below along with accompanying photographic evidence as outlined in the accompanying drawings.
Case Study 1:
The ointment according to the invention was tested on a seven year old scar and the results of the use of the ointment are illustrated in
Case Study 2:
The ointment according to the invention was tested on an old injury from over 13 years ago that had recently been opened up. After numerous costly vet visits and bandaging for almost 12 months, the ointment according to the present invention was used on the wound. The initial wound is shown in
Case Study 3:
A horse had a cluster of scaroids on his upper leg prior to treatment with the ointment according to the invention. After application of the ointment, the scaroids have completely gone and there are no signs of the scaroids coming back. The process took approximately 12-14 weeks from first application of the ointment to the final application. It is believed that the process would probably have taken less time if there was less hair in the way but it was not possible to clip the horse during treatment. The sequential progression of the wound from start of treatment to finish of treatment is shown in
Case Study 4:
In
Case Study 5:
In
Referring to
By day 40 after the initial injury, (i.e. the 6th day of application of the topical healing formulation) the horse was placed in a light soft mesh rug to help protect the wound and the topical healing formulation was applied to the wound daily. The wound had been producing a lot of fluid that builds up on the rug and this has been removed daily to allow the application of the topical healing formulation and to prevent blowfly strike. The wound continued to contract, further epithelial migration occurred and the muscle tissue continued to fill. The topical healing formulation kept the wound moist and was easy to apply. The application of the topical healing formulation is shown in
By day 56 (as illustrated in
By day 67, the horse's carers have been applying the topical healing formulation every 2-3 days. Hair and skin growth has been impressive. The horse's carers have been letting the horse have short amounts of time out of her rug between applications and the wound appeared the be drier than usual. Under the ‘scab’, it was observed that the flesh was very healthy and fresh. The epithelial migration and wound contraction continued to impress.
By day 80 (as illustrated in
By day 104 (as illustrated in
By day 134 (as illustrated in
By day 164, the horses owners have continued to apply the topical healing formulation according to the invention to the wound daily. The pink skin is slowly turning dark and small hair follicles are forming over the scar. The top line of the original injury and the front and bottom lines are barely visible anymore.
Case Study 6:
Case study 6 illustrates the use of the topical healing formulation according to the invention on a horse with a scar and a lump that has been removed. There was a large lump over a even larger scar from a prior injury site (as illustrated in
The carer for the horse shown in
Case Study 7:
Another particularly serious injury to a horse is shown in
Case Study 8:
Case study 8 demonstrates the benefits of the topical healing formulation according to the invention on other animals, in this case, a dog. The topical healing formulation was used on a great dane/bull mastiff/wolfhound cross that had been suffering from flea and fly bite allergy dermatitis. Several other treatments including topical ointments, sprays and washes were tried to resolve the issue however none of those offerings proved successful. As a consequence, the dog continued to scratch herself excessively and her skin was very raw. After use of the topical healing formulation according to the invention for a limited period of time, the dog has almost completely stopped all scratching and her temperament has improved. Her skin is no longer raw and her hair is growing back relatively soft.
Case Study 9:
Case Study 9 further demonstrates the use of the topical healing formulation on a horse. The horse had an accident and as a result of which was left with scarring. The scars were over three years old prior to the use of the topical wound formulation according to the invention. The horse sustained serious injuries to both of her hind legs, as well as her off side hip, shoulder, ribs, cheek and knee and underwent seven months of treatment to heal the various wounds. The owner previously tried numerous different offerings in an attempt to heal the scars and promote hair growth including paw paw ointment, zinc and castor oil cream, bio oil, Cornucrescine, honey and many more ointments however none of these proved successful. The owner of the horse applied the topical healing formulation ointment to the horse's scars once (and sometimes twice) a day for a period of 9 weeks. After just 2 applications, the owner could see hair growing on the animal's cheek. The photos in
Referring to
Case Study 10:
It has been found that there is a synergistic effect achieved by combining the Gotu Kola, the Common Plantain, the Figwort, the Yarrow and the Pau d'Arco. Omission of one of the five main active ingredients results in significantly diminished results. A small batch of the topical healing formulation was made without the Figwort and with a relatively smaller amount of Pau d'Arco. The batch had similar quantities to the composition of ointment batch shown in Table 1(a) above but with no Figwort and no more than 20 g of Pau d'Arco. The results were significantly diminished and had little impact on the healing of wounds and scar tissue.
In this specification the terms “comprise, comprises, comprised and comprising” and the terms “include, includes, included and including” are all deemed totally interchangeable and should be afforded the widest possible interpretation. The invention is not limited to the embodiments hereinbefore described and may be varied in both construction and detail within the scope of the claims.
| Number | Date | Country | Kind |
|---|---|---|---|
| 1517878.3 | Oct 2015 | GB | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2016/074244 | 10/10/2016 | WO | 00 |
